News

Lung cancer bypasses breast cancer as leading cause of cancer death for women in developed countries


 

References

An estimated 14.1 million new cancer cases and 8.2 million cancer deaths occurred in 2012, although incidences of certain cancers, such as lung cancer, are increasing rapidly in less developed countries, according to GLOBOCAN 2012, a research project produced by the International Agency for Research on Cancer (IARC) to determine worldwide estimates of cancer incidence and mortality.

Interestingly, less developed countries account for only 57% of cases and 65% of cancer deaths worldwide, despite their share of the population surveyed being significantly larger than that of more developed countries.

Lung cancer is the leading cause of cancer death among males in both more and less developed countries, and among females in more developed countries. Breast cancer remains the leading cause of cancer death among females in less developed countries, although this may change as breast cancer testing becomes more commonplace and more countries adapt Western lifestyle habits, the researchers noted.

Read the full article here: CA Cancer J. Clin. 2015;000:000-000 (doi:10.3322/caac.21262).

Recommended Reading

Nivolumab monotherapy reaches advanced squamous NSCLC
MDedge Hematology and Oncology
Carboplatin, etoposide yield similar survival in NSCLC
MDedge Hematology and Oncology
Proposed criteria for lung cancer screening with LDCT may not be most efficient
MDedge Hematology and Oncology
First-line crizotinib superior for ALK-positive NSCLC
MDedge Hematology and Oncology
Hookah, snus users more likely to start smoking
MDedge Hematology and Oncology
Cancer patients with incidental VTE have high risk of recurrent thrombi
MDedge Hematology and Oncology
Ramucirumab approved for metastatic NSCLC
MDedge Hematology and Oncology
ASCO, AACR recommend against using e-cigarettes as first line for smoking cessation for cancer patients
MDedge Hematology and Oncology
Adding cisplatin to docetaxel monotherapy provides no benefit for elderly with NSCLC
MDedge Hematology and Oncology
Metformin linked to lower risk of lung cancer in diabetic nonsmokers
MDedge Hematology and Oncology